Contact Information

Oak Avenue, Manhattan Beach, California 90266

Contact Us

Neuronetics Inc. (STIM) announced a $3.7 million loss in the fourth quarter on Tuesday.

On a per-share basis, the Malvern, Pennsylvania-based corporation posted a 19-cent loss.

The medical device company specializing in behavioral conditions made $15.6 million in sales during the quarter.


The company’s loss for the year was reduced to $27.5 million, or $1.46 per share. $49.2 million in revenue was registered.

Neuronetics expects sales in the range of $11 million to $12 million for the current quarter, which ends in April.

Revenue for the full year is projected to be in the range of $58 million to $62 million, according to the company.

Since the beginning of the year, shares of Neuronetics have increased by 49%. In the last year, the stock has risen fivefold.

READ:  Biden Expands Pandemic Assistance for Tenants, Waiting for Renters
Notify of
Inline Feedbacks
View all comments